SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-017407
Filing Date
2022-11-10
Accepted
2022-11-10 16:05:54
Documents
15
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ganx-20221110x8k.htm   iXBRL 8-K 34726
2 EX-99.1 ganx-20221110xex99d1.htm EX-99.1 227228
3 GRAPHIC ganx-20221110xex99d1002.jpg GRAPHIC 6598
  Complete submission text file 0001558370-22-017407.txt   419404

Data Files

Seq Description Document Type Size
4 EX-101.SCH ganx-20221110.xsd EX-101.SCH 3751
5 EX-101.DEF ganx-20221110_def.xml EX-101.DEF 2839
6 EX-101.LAB ganx-20221110_lab.xml EX-101.LAB 18020
7 EX-101.PRE ganx-20221110_pre.xml EX-101.PRE 10723
9 EXTRACTED XBRL INSTANCE DOCUMENT ganx-20221110x8k_htm.xml XML 5082
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 221377043
SIC: 2834 Pharmaceutical Preparations